BioLineRx Ltd. (BLRX)
2.22
+0.01
(+0.45%)
USD |
NASDAQ |
Oct 09, 16:00
2.22
0.00 (0.00%)
After-Hours: 20:00
BioLineRx Market Cap : 9.698M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 9.654M |
| October 07, 2026 | 9.632M |
| October 06, 2026 | 10.01M |
| October 05, 2026 | 10.13M |
| October 02, 2026 | 10.35M |
| October 01, 2026 | 10.27M |
| September 30, 2026 | 10.27M |
| September 29, 2026 | 10.31M |
| September 28, 2026 | 10.62M |
| September 25, 2026 | 11.36M |
| September 24, 2026 | 11.01M |
| September 23, 2026 | 11.18M |
| September 22, 2026 | 10.62M |
| September 21, 2026 | 10.83M |
| September 18, 2026 | 10.86M |
| September 17, 2026 | 11.05M |
| September 16, 2026 | 10.83M |
| September 15, 2026 | 11.01M |
| September 14, 2026 | 10.62M |
| September 11, 2026 | 10.96M |
| September 10, 2026 | 11.22M |
| September 09, 2026 | 11.14M |
| September 08, 2026 | 11.31M |
| September 04, 2026 | 11.66M |
| September 03, 2026 | 11.75M |
| Date | Value |
|---|---|
| September 02, 2026 | 11.97M |
| September 01, 2026 | 12.06M |
| August 31, 2026 | 12.23M |
| August 28, 2026 | 11.36M |
| August 27, 2026 | 12.06M |
| August 26, 2026 | 11.79M |
| August 25, 2026 | 12.40M |
| August 24, 2026 | 13.05M |
| August 21, 2026 | 12.23M |
| August 20, 2026 | 12.01M |
| August 19, 2026 | 12.75M |
| August 18, 2026 | 12.40M |
| August 17, 2026 | 11.49M |
| August 14, 2026 | 12.01M |
| August 13, 2026 | 11.83M |
| August 12, 2026 | 11.71M |
| August 11, 2026 | 12.08M |
| August 10, 2026 | 11.80M |
| August 07, 2026 | 11.79M |
| August 06, 2026 | 12.14M |
| August 05, 2026 | 11.82M |
| August 04, 2026 | 12.01M |
| August 03, 2026 | 11.56M |
| July 31, 2026 | 12.27M |
| July 30, 2026 | 11.75M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| XTL Biopharmaceuticals Ltd. | 4.684M |
| Kamada Ltd. | 465.59M |
| Can-Fite BioPharma Ltd. | 4.114M |
| Eocene Ltd. | 3.515M |
| Revium Recovery, Inc. | 86.84M |
Market Cap Related Metrics
| PS Ratio | 6.971 |
| PEG Ratio | -0.0250 |
| Price to Book Value | 0.7043 |
| Price | 2.22 |
| Earnings Yield | -81.94% |
| PEGY Ratio | -0.0250 |